BLTG.L Regulatory News (BLTG)

8 February 2011

Regenersis plc 

("Regenersis" or the "Group")

Board Changes 

Regenersis plc (LSE AIM: RGS), a strategic outsourcing partner to many of the world's leading consumer technology companies, announces a number of changes to its Board of Directors (the "Board"). 

Jeff Hewitt, David Holland and David Gilbert have today stepped down from their respective Non-Executive positions on the Board. 

In turn, the Board has appointed Matthew Peacock as Non-Executive Chairman and Michael Peacock and Andrew Lee as Non-Executive Directors.   

These changes to the Board take effect immediately.

Matthew Peacock is the founder partner of Hanover Investors Management LLP which is significant shareholder of Regenersis. Hanover Investors is a specialist turnaround investment firm based in London. Matthew has led investments for over 20 years in, amongst other sectors, manufacturing, outsourced business services, chemicals, financial services, textiles and logistics. Prior to this, he ran the International M&A team in London at Barclays de Zoete Wedd's, having started his career at Credit Suisse First Boston, in New York. He holds a Masters degree in Law from Cambridge University. Matthew is also Chairman of Fairpoint Group plc and Singer Capital Markets Limited, a London stockbroking and corporate advisory firm, and a Non-Executive Director of STV Group plc. 

Michael Peacock was most recently the Finance Director at Victrex plc. Victrex is a global manufacturer of innovative, high performance thermoplastic polymers, working with customers and end users to deliver technology driven solutions to the challenges and opportunities they face. Michael was formerly with Barclays de Zoete Wedd's corporate finance department before moving into industry as a Finance Director, initially with Viva! Health and Leisure Clubs Limited.

Andrew Lee served as Managing Director of marketing and logistics service provider Dataforce Group Limited from 2004, successfully selling the business to Twenty plc in 2006 and becoming a director of Twenty plc. Prior to that, he spent four years as Group Operations Director of N Brown Group plc, a UK catalogue and internet clothes retailer with an £800 million market capitalisation, and 15 years in the Unipart Group where he became managing director of Demand Chain Logistics. 

Matthew Peacock and Michael Peacock are not related.

Gary Stokes, Chief Executive Officer of Regenersis, said: 

"I would like to thank the outgoing Non-Executive Directors for their excellent contribution and wish them all the best for the future.

"I very much look forward to drawing on the support and experience of our new Board members." 

The following information is provided in compliance with the provisions of Schedule 2(g) of the AIM Rules for Companies:

Matthew Roy Peacock (age 49), as a partner in Hanover Investors Management LLP, has an indirect holding of 6,347,500 ordinary shares equating to 14.16 per cent. of the issued share capital of the Company. 

Matthew Peacock has been a director or partner of the following companies during the past five years:

Matthew Peacock was a director of Plasmon PLC from 18 May 2007 to 23 May 2008. In October 2008 Plasmon PLC was put into administration.

There are no further disclosures to be made in respect of Mr Matthew Peacock under the provisions of paragraph g of Schedule Two of the AIM Rules for Companies. 

Michael William Peacock (age 52) has been a director or partner of the following companies during the past five years:

In 1991 Michael Peacock became Group Finance Director of Peaco Sport Limited ("Peaco"). As part of his role, in April 1992, he was appointed a Director of Running Wild Limited, a non-core business that had been acquired as part of a group of companies by Peaco in 1991. Michael Peacock's role at Running Wild was to wind down its remaining insignificant trading operations and to put it into liquidation. Running Wild was placed into creditors voluntary liquidation in December 1992, the principal creditor being another wholly owned subsidiary of Peaco.

There are no further disclosures to be made in respect of Mr Michael Peacock under the provisions of paragraph g of Schedule Two of the AIM Rules for Companies. 

Andrew Stephen Lee (age 52) has been a director or partner of the following companies during the past five years:

There are no further disclosures to be made in respect of Mr Andrew Lee under the provisions of paragraph g of Schedule Two of the AIM Rules for Companies.

Ends